Azenta US Inc.

Company Snapshot

Founded: 1978
Entity Type: Public
Employees: 3,000
Region: North America
Revenue: $593.8 Millions
Revenue Year: 2025
Headquarter: Massachusetts, U.S.
Key Geographics: North America, Africa, China, U.K., Rest of Europe, Asia-Pacific/Other
Corporate Address: 200 Summit Drive 6th Floor, Burlington Massachusetts 01803 U.S. Tel. +1-978-262-2626 www.azenta.com

Company Overview

Azenta US Inc., formerly known as Brooks Automation, is a leading provider of life sciences solutions designed to accelerate the exploration, development, and delivery of impactful breakthroughs and therapies. It offers products and services developed internally. It operates through two main segments: Life Sciences Products and Life Sciences Services. The life sciences products business mainly covers the automated cold storage solutions for chemical and biological compound samples. The life sciences services business is the primary provider of solutions that address the diverse needs of customers across management, genomic analysis, and the care of biological samples, for healthcare, biotech, pharmaceutical, clinical, and academic research. Azenta US Inc. offers a comprehensive portfolio of gene synthesis products and services under its GENEWIZ brand. These products cater to various research needs and applications.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Azenta US Inc. In Reports

Gene Synthesis: Technologies and Global Markets

This report explores the global gene synthesis technologies market by method, application, end user and region, with patent analysis and competitive insights to 2031.

Gene Synthesis: Technologies and Global Markets

BCC Research Market Analyst says global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028 at a CAGR of 15.8%.

Biobanking: Technologies and Global Markets

BCC Research Market Report for biobanking is estimated to increase from $61.1 billion in 2021 to $76.2 billion by 2026, at a compound annual growth rate of 4.5%

Company's Business Segments

  • Sample Management Solutions : The Sample Management Solutions business resources operate as a single business unit offering end-to-end sample management products and services, including Sample Repository Services, or SRS, and Core Products (Automated Stores, Cryogenic Systems, Automated Sample Tube, Consumables and Instruments and Controlled Rate Thawing Devices).
  • Multiomics : The Multiomics business resources operate as a single business unit offering genomic and other sample analysis services, including gene sequencing, synthesis editing and related services.
  • B Medical Systems : The B Medical Systems business resources operate as a single business unit focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations.

Applications/End User Industries

  • Vaccine Development
  • Cell and Gene Therapy
  • Sustainable & Energy Efficient Storage Solutions
  • Clinical Trial Services & Support
  • IVD Development Support
  • Sample Connect for Pharma & Biopharma
  • Better Storage Management
  • Discovery
  • Compound Management & Biologics
AI Sentiment